Inhibitory effect of zinc on hypoxic HIF-1 activation in astrocytes

NeuroReport

Volumn 19, Issue 10, 2008, Pages 1065-1068

  Kim, Insook ^a   Kim, Chul Hoon ^a   Seo, Gi Ho ^a   Kim, Hyun Soo ^a   Lee, Jinu ^b   Kim, Dong Goo ^a   Ahn, Young Soo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b CHA University   (South Korea)

Author keywords

Astrocytes; Erythropoietin; Hypoxia; Hypoxia inducible factor 1; Zinc

Indexed keywords

DNA; ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MESSENGER RNA; PYRROLIDINE DITHIOCARBAMATE; ZINC;

ARTICLE; ASTROCYTE; CELL MIGRATION; CELL NUCLEUS; CONTROLLED STUDY; DIMERIZATION; DNA BINDING; ENHANCER REGION; HUMAN; HUMAN CELL; HYPOXIA; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN TRANSPORT; TRANSCRIPTION INITIATION;

EID: 67249146840     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e328304d9ac     Document Type: Article

References (25)

1. Giaccia A, Siim BG, Johnson RS. HIF-1 as a target for drug development. Nat Rev Drug Discov 2003; 2:803-811.
2. Hewitson KS, Schofield CJ. The HIF pathway as a therapeutic target. Drug Discov Today 2004; 9:704-711.
3. Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, Gallo RL, et al. HIF-1α expression regulates the bactericidal capacity of phagocytes. J Clin Invest 2005; 115:1806-1815.
4. Kallio PJ, Pongratz I, Gradin K, McGuire J, Poellinger L. Activation of hypoxia-inducible factor 1α: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc Natl Acad Sci U S A 1997; 94:5667-5672.
5. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399:271-275.
6. Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, et al. Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 2000; 275:25733-25741.
7. 2 sensing. Science 2001; 292:464-468.
8. Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005; 105:659-669.
9. Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 1993; 90:4304-4308.
10. Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Kuliszewski M, et al. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFβ(3). J Clin Invest 2000; 105:577-587.
11. Frederickson CJ, Koh JY, Bush AI. The neurobiology of zinc in health and disease. Nat Rev Neurosci 2005; 6:449-462.
12. Leis JA, Bekar LK, Walz W. Potassium homeostasis in the ischemic brain. Glia 2005; 50:407-416.
13. Trendelenburg G, Dirnagl U. Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 2005; 50:307-320.
14. Chun YS, Choi E, Kim GT, Lee MJ, Lee SE, Kim MS, et al. Zinc induces the accumulation of hypoxia-inducible factor (HIF)-1α, but inhibits the nuclear translocation of HIF-1β, causing HIF-1 inactivation. Biochem Biophys Res Commun 2000; 268:652-656.
15. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades. Nature 2001; 412:641-647.
16. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 2002; 22:10291-10301.
17. Kim CH, Kim JH, Xu J, Hsu CY, Ahn YS. Pyrrolidine dithiocarbamate induces bovine cerebral endothelial cell death by increasing the intracellular zinc level. J Neurochem 1999; 72:1586-1592.
18. Kim I, Kim CH, Kim JH, Lee J, Choi JJ, Chen ZA, et al. Pyrrolidine dithiocarbamate and zinc inhibit proteasome-dependent proteolysis. Exp Cell Res 2004; 298:229-238.
19. Park SE, Park JW, Cho YS, Ryu JH, Paick JS, Chun YS. HIF-1α promotes survival of prostate cells at a high zinc environment. Prostate 2007; 67:1514-1523.
20. Bartesaghi S, Marinovich M, Corsini E, Galli CL, Viviani B. Erythropoietin: a novel neuroprotective cytokine. Neurotoxicology 2005; 26:923-928.
21. 2+ from brain tissue during activity. Nature 1984; 308:734-736.
22. Wotzlaw C, Otto T, Berchner-Pfannschmidt U, Metzen E, Acker H, Fandrey J. Optical analysis of the HIF-1 complex in living cells by FRET and FRAP. FASEB J 2007; 21:700-707.
23. Chilov D, Camenisch G, Kvietikova I, Ziegler U, Gassmann M, Wenger RH. Induction and nuclear translocation of hypoxia-inducible factor-1 (HIF-1): heterodimerization with ARNT is not necessary for nuclear accumulation of HIF-1α. J Cell Sci 1999; 112 (Pt 8):1203-1212.
24. Hirsila M, Koivunen P, Xu L, Seeley T, Kivirikko KI, Myllyharju J. Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway. FASEB J 2005; 19:1308-1310.
25. Yuan Y, Hilliard G, Ferguson T, Millhorn DE. Cobalt inhibits the interaction between hypoxia-inducible factor-α and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-α. J Biol Chem 2003; 278:15911-15916.